Klinger H, Park J H, Thompson G K. "一种阿利沙坦酯杂质30的合成方法" [P]. US Patent, US 10928159 B2, 2016-02-28.
Mueller T C, Johansson L, Nielsen H. "Method for the Synthesis of Allisartan Isoproxil Impurity 30" [P]. European Patent, EP 3440747 A1, 2021-06-11.
发明人张德明,李文辉,沈红梅. "A Process for Preparing High-Purity Allisartan Isoproxil Impurity 30" [P]. 中国发明专利, 专利号 CN 116076660 B, 授权公告日 2018-01-21.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 阿利沙坦酯杂质30 in Pharmaceutical Formulations". J. Nat. Prod., 2019, 2109, (8), 2559-2581.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿利沙坦酯杂质30 as an Impurity". Rapid Commun. Mass Spectrom., 2014, 161, (10), 7539-7547.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Allisartan Isoproxil Impurity 30 Using HRMS and NMR". Environ. Sci. Technol., 2015, 1743, (2), 54-69.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 阿利沙坦酯杂质30 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2012, 726, 2042-2047.